Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
The global Intravenous Immunoglobulin (IVIg) market was valued at US$ 9735.3 million in 2020 and is expected to reach US$ 14540 million by the end of 2029, growing at a CAGR of 5.9% during 2021-2029.
This report focuses on Intravenous Immunoglobulin (IVIg) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Intravenous Immunoglobulin (IVIg) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Intravenous Immunoglobulin (IVIg) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
1 Intravenous Immunoglobulin (IVIg) Market Overview
1.1 Product Overview and Scope of Intravenous Immunoglobulin (IVIg)
1.2 Intravenous Immunoglobulin (IVIg) Segment by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) Segment by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Comparison by Application: (2021-2029)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts
1.4.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2016-2029
1.4.2 Global Intravenous Immunoglobulin (IVIg) Sales 2016-2029
1.4.3 Intravenous Immunoglobulin (IVIg) Market Size by Region: 2016 Versus 2021 Versus 2029
2 Intravenous Immunoglobulin (IVIg) Market Competition by Manufacturers
2.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites, Area Served, Product Type
2.5 Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
2.5.1 Intravenous Immunoglobulin (IVIg) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue
2.5.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario by Region
3.1 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.3.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country
3.3.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.4.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country
3.4.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Region
3.5.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region
3.5.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.6.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country
3.6.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.7.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country
3.7.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Intravenous Immunoglobulin (IVIg) Historic Market Analysis by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
4.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2021)
4.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2016-2021)
5 Global Intravenous Immunoglobulin (IVIg) Historic Market Analysis by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
5.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2016-2021)
5.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Corporation Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Corporation Information
6.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Description and Business Overview
6.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Corporation Information
6.12.2 BPL Intravenous Immunoglobulin (IVIg) Description and Business Overview
6.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Corporation Information
6.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
7.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
7.4 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Intravenous Immunoglobulin (IVIg) Distributors List
8.3 Intravenous Immunoglobulin (IVIg) Customers
9 Intravenous Immunoglobulin (IVIg) Market Dynamics
9.1 Intravenous Immunoglobulin (IVIg) Industry Trends
9.2 Intravenous Immunoglobulin (IVIg) Growth Drivers
9.3 Intravenous Immunoglobulin (IVIg) Market Challenges
9.4 Intravenous Immunoglobulin (IVIg) Market Restraints
10 Global Market Forecast
10.1 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Intravenous Immunoglobulin (IVIg) by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Intravenous Immunoglobulin (IVIg) by Type (2022-2029)
10.2 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Intravenous Immunoglobulin (IVIg) by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Intravenous Immunoglobulin (IVIg) by Application (2022-2029)
10.3 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intravenous Immunoglobulin (IVIg) by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Intravenous Immunoglobulin (IVIg) by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Comparison by Application (2021-2029)
Table 3. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Intravenous Immunoglobulin (IVIg) Covered in This Study
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) of Key Manufacturers (2016-2021)
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites and Area Served
Table 11. Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) & (K Bottle)
Table 16. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Table 17. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 19. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 20. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 22. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 23. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 24. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) & (K Bottle)
Table 27. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 31. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 32. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 35. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 38. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2016-2021)
Table 39. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 40. Global Intravenous Immunoglobulin (IVIg) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2016-2021)
Table 42. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2016-2021)
Table 43. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2016-2021)
Table 44. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 45. Global Intravenous Immunoglobulin (IVIg) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2016-2021)
Table 47. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2016-2021)
Table 48. Baxter Corporation Information
Table 49. Baxter Description and Business Overview
Table 50. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 51. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 52. Baxter Recent Developments/Updates
Table 53. Grifols Corporation Information
Table 54. Grifols Description and Business Overview
Table 55. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 56. Grifols Intravenous Immunoglobulin (IVIg) Product
Table 57. Grifols Recent Developments/Updates
Table 58. CSL Corporation Information
Table 59. CSL Description and Business Overview
Table 60. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 61. CSL Intravenous Immunoglobulin (IVIg) Product
Table 62. CSL Recent Developments/Updates
Table 63. Octapharma Corporation Information
Table 64. Octapharma Description and Business Overview
Table 65. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 66. Octapharma Intravenous Immunoglobulin (IVIg) Product
Table 67. Octapharma Recent Developments/Updates
Table 68. Biotest Corporation Information
Table 69. Biotest Description and Business Overview
Table 70. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 71. Biotest Intravenous Immunoglobulin (IVIg) Product
Table 72. Biotest Recent Developments/Updates
Table 73. Kedrion Corporation Information
Table 74. Kedrion Description and Business Overview
Table 75. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 76. Kedrion Intravenous Immunoglobulin (IVIg) Product
Table 77. Kedrion Recent Developments/Updates
Table 78. Hualan Bio Corporation Information
Table 79. Hualan Bio Description and Business Overview
Table 80. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 81. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
Table 82. Hualan Bio Recent Developments/Updates
Table 83. CNBG Corporation Information
Table 84. CNBG Description and Business Overview
Table 85. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 86. CNBG Intravenous Immunoglobulin (IVIg) Product
Table 87. CNBG Recent Developments/Updates
Table 88. Shanghai RAAS Corporation Information
Table 89. Shanghai RAAS Description and Business Overview
Table 90. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 91. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
Table 92. Shanghai RAAS Recent Developments/Updates
Table 93. CBPO Corporation Information
Table 94. CBPO Description and Business Overview
Table 95. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 96. CBPO Intravenous Immunoglobulin (IVIg) Product
Table 97. CBPO Recent Developments/Updates
Table 98. LFB Group Corporation Information
Table 99. LFB Group Description and Business Overview
Table 100. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 101. LFB Group Intravenous Immunoglobulin (IVIg) Product
Table 102. LFB Group Recent Developments/Updates
Table 103. BPL Corporation Information
Table 104. BPL Description and Business Overview
Table 105. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 106. BPL Intravenous Immunoglobulin (IVIg) Product
Table 107. BPL Recent Developments/Updates
Table 108. Sichuan Yuanda Shuyang Corporation Information
Table 109. Sichuan Yuanda Shuyang Description and Business Overview
Table 110. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 111. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
Table 112. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Intravenous Immunoglobulin (IVIg) Distributors List
Table 116. Intravenous Immunoglobulin (IVIg) Customers List
Table 117. Intravenous Immunoglobulin (IVIg) Market Trends
Table 118. Intravenous Immunoglobulin (IVIg) Growth Drivers
Table 119. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 120. Intravenous Immunoglobulin (IVIg) Market Restraints
Table 121. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2022-2029) & (K Bottle)
Table 122. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2022-2029)
Table 123. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 124. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type (2022-2029)
Table 125. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2022-2029) & (K Bottle)
Table 126. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2022-2029)
Table 127. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 128. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Application (2022-2029)
Table 129. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2022-2029) & (K Bottle)
Table 130. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Region (2022-2029)
Table 131. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 132. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Region (2022-2029)
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Global Intravenous Immunoglobulin (IVIg) Market Share by Type in 2020 & 2029
Figure 3. IVIg Liquid Product Picture
Figure 4. IVIg Powder Product Picture
Figure 5. Global Intravenous Immunoglobulin (IVIg) Market Share by Application in 2020 & 2029
Figure 6. Immunodeficiency
Figure 7. Autoimmune Disease
Figure 8. Acute Infection
Figure 9. Global Intravenous Immunoglobulin (IVIg) Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 10. Global Intravenous Immunoglobulin (IVIg) Market Size 2016-2029 (US$ Million)
Figure 11. Global Intravenous Immunoglobulin (IVIg) Sales 2016-2029 (K Bottle)
Figure 12. Global Intravenous Immunoglobulin (IVIg) Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 13. Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers in 2020
Figure 14. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Intravenous Immunoglobulin (IVIg) Players: Market Share by Revenue in 2020
Figure 16. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Figure 18. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2020
Figure 19. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)
Figure 20. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in 2020
Figure 21. U.S. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type (2016-2021)
Figure 44. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Application (2016-2021)
Figure 45. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Application in 2020
Figure 46. Revenue Share of Intravenous Immunoglobulin (IVIg) by Application (2016-2021)
Figure 47. Revenue Share of Intravenous Immunoglobulin (IVIg) by Application in 2020
Figure 48. Manufacturing Cost Structure of Intravenous Immunoglobulin (IVIg)
Figure 49. Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure 50. Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
